- Filed
- May 15, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 7.53M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 0 sh |
| Capex | Q1 2024 · Mar 31, 2024 | $4.13M |
| Capex | Q1 2024 · Mar 31, 2023 | $2.78M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | $45.14M |
| Operating Cash Flow restated | Q1 2024 · Mar 31, 2023 | −$329K |
| Long Term Debt | Q1 2024 · Mar 31, 2024 | $80.86M |
| Long Term Debt | Q1 2024 · Dec 31, 2023 | $80.64M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $74.94M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $28.54M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | −$167.45M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | −$161.73M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $233.83M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $169.05M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $365.81M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $303.74M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $323.96M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $277.8M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $421.92M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $374.45M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$1.22 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $0.00 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | −$1.22 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | $0.00 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $28.28M |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $23.72M |
| Net Income | Q1 2024 · Mar 31, 2024 | −$7.8M |
| Operating Income | Q1 2024 · Mar 31, 2024 | −$19.24M |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | −$491K |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $354.95M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $278.53M |
| Revenue | Q1 2024 · Mar 31, 2024 | $364.34M |
| Revenue | Q1 2024 · Mar 31, 2023 | $303.73M |